This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: National Institute of Health and Medical Research, Johns Hopkins University. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,853 
1 out of 3,798 
Years Active: 2012-2016
Title: Marie Lavollay: Innovator in Bacterial Infection Treatment
Introduction
Marie Lavollay is a prominent inventor based in Bourg la Reine, France. She has made significant contributions to the field of medical research, particularly in the treatment of bacterial infections. With a total of 2 patents, her work has the potential to impact the healthcare industry significantly.
Latest Patents
Marie Lavollay's latest patents focus on innovative methods for treating bacterial infections. One of her patents details methods for treatment that target the peptidoglycan layer, a crucial component of the bacterial cell wall. This layer comprises 4→3 and 3→3 transpeptide cross-linkages, which are catalyzed by D,D- and L,D-transpeptidases. Her research provides methods for treating bacterial infections with agents that inhibit L,D-transpeptidases, either alone or in combination with D,D-transpeptidase inhibitors. Additionally, she has developed methods for treating chronic stage tuberculosis using agents that inhibit enzymes with L,D-transpeptidase activity. Another patent outlines a method for treating individuals affected by latent tuberculosis, which involves administering an effective amount of one or more carbapenem compounds.
Career Highlights
Throughout her career, Marie has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale and The Johns Hopkins University. Her work in these organizations has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Marie Lavollay has collaborated with notable colleagues, including Jean-Luc Mainardi and Michel Arthur. These partnerships have enriched her research and expanded the scope of her innovations.
Conclusion
Marie Lavollay is a trailblazer in the field of bacterial infection treatment, with her patents paving the way for new therapeutic approaches. Her dedication to research and collaboration with leading institutions and colleagues highlights her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile